These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 26305537)

  • 1. Perspectives on benefit-risk decision-making in vaccinology: Conference report.
    Greenberg M; Simondon F; Saadatian-Elahi M
    Hum Vaccin Immunother; 2016; 12(1):176-81. PubMed ID: 26305537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advocating for efforts to protect African children, families, and communities from the threat of infectious diseases: report of the First International African Vaccinology Conference.
    Wiysonge CS; Waggie Z; Hawkridge A; Schoub B; Madhi SA; Rees H; Hussey G
    Pan Afr Med J; 2016; 23():53. PubMed ID: 27217879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies for decision-making on vaccine use: the French experience.
    Loulergue P; Floret D; Launay O
    Expert Rev Vaccines; 2015 Jul; 14(7):917-22. PubMed ID: 25913015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine impact: Benefits for human health.
    Doherty M; Buchy P; Standaert B; Giaquinto C; Prado-Cohrs D
    Vaccine; 2016 Dec; 34(52):6707-6714. PubMed ID: 27773475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006.
    Menzies R; Turnour C; Chiu C; McIntyre P
    Commun Dis Intell Q Rep; 2008 Jun; 32 Suppl():S2-67. PubMed ID: 18711998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies and actions of multi-purpose health communication on vaccine preventable infectious diseases in order to increase vaccination coverage in the population: The ESCULAPIO project.
    Bechini A; Bonanni P; Lauri S; Tiscione E; Levi M; Prato R; Fortunato F; Martinelli D; Gasparini R; Panatto D; Amicizia D; Coppola RC; Pellizzari B; Tabacchi G; Costantino C; Vitale F; Iannazzo S; Boccalini S
    Hum Vaccin Immunother; 2017 Feb; 13(2):369-375. PubMed ID: 28215120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [From the licensure of vaccines to the recommendation of the Standing Committee on Vaccination in Germany : criteria for the assessment of benefits and risks].
    Pfleiderer M; Wichmann O
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Mar; 58(3):263-73. PubMed ID: 25566841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On pins and needles: how vaccines are portrayed on Pinterest.
    Guidry JP; Carlyle K; Messner M; Jin Y
    Vaccine; 2015 Sep; 33(39):5051-6. PubMed ID: 26319742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The decision making process on new vaccines introduction in South Africa.
    Ngcobo NJ; Cameron NA
    Vaccine; 2012 Sep; 30 Suppl 3():C9-13. PubMed ID: 22939028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innovation, urgency and acceptance at the 9th Vaccine Renaissance.
    De Groot AS; Moise L
    Hum Vaccin Immunother; 2016 Dec; 12(12):3186-3188. PubMed ID: 28010520
    [No Abstract]   [Full Text] [Related]  

  • 11. Strengthening vaccination policies in Latin America: an evidence-based approach.
    Tapia-Conyer R; Betancourt-Cravioto M; Saucedo-Martínez R; Motta-Murguía L; Gallardo-Rincón H
    Vaccine; 2013 Aug; 31(37):3826-33. PubMed ID: 23357196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence-based decision making for vaccines: the need for an ethical foundation.
    Field RI; Caplan AL
    Vaccine; 2012 Feb; 30(6):1009-13. PubMed ID: 22197581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vaccination perspectives].
    Saliou P; Plotkin S
    Sante; 1994; 4(3):237-41. PubMed ID: 7921696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine strategies: Optimising outcomes.
    Hardt K; Bonanni P; King S; Santos JI; El-Hodhod M; Zimet GD; Preiss S
    Vaccine; 2016 Dec; 34(52):6691-6699. PubMed ID: 27887796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ISV Congress back to Europe.
    Doolan DL; Lu S
    Hum Vaccin Immunother; 2018; 14(9):2101-2104. PubMed ID: 30285587
    [No Abstract]   [Full Text] [Related]  

  • 16. Informing vaccine decision-making: A strategic multi-attribute ranking tool for vaccines-SMART Vaccines 2.0.
    Knobler S; Bok K; Gellin B
    Vaccine; 2017 Jan; 35 Suppl 1():A43-A45. PubMed ID: 28017435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 12th Annual Conference on Vaccine Research.
    O'Brien J
    Expert Rev Vaccines; 2009 Sep; 8(9):1139-42. PubMed ID: 19722886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Basis for vaccine recommendations].
    Lévy-Bruhl D
    Med Sci (Paris); 2007 Apr; 23(4):404-8. PubMed ID: 17433231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond efficacy: The full public health impact of vaccines.
    Saadatian-Elahi M; Horstick O; Breiman RF; Gessner BD; Gubler DJ; Louis J; Parashar UD; Tapia R; Picot V; Zinsou JA; Nelson CB
    Vaccine; 2016 Feb; 34(9):1139-47. PubMed ID: 26808648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introduction. Maternal immunization - Promises and concerns.
    Englund JA
    Vaccine; 2015 Nov; 33(47):6372-3. PubMed ID: 26263199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.